Yield10 Bioscience, Inc.
About Yield10 Bioscience, Inc.
Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 is leveraging an extensive track record of innovation based around optimizing the flow of carbon in living systems. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing seed production, Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and corn. Yield10 is based in Woburn, MA.YEAR FOUNDED:
1992
LEADERSHIP:
CEO: Oliver P. Peoples
CAO: Charles B. Haaser
CSO: Kristi Snell
FOLLOW YIELD10 BIOSCIENCE:
Tweets by Yield10 Bioscience
113 articles about Yield10 Bioscience, Inc.
-
Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results
4/1/2024
Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the fourth quarter and full year ended December 31, 2023.
-
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024
3/28/2024
Yield10 Bioscience, Inc. announced that the Company will report its fourth quarter and full year 2023 financial results and provide a corporate update on Monday, April 1, 2024.
-
Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada
3/26/2024
Yield10 Bioscience, Inc. reported that the Plant Biosafety Office of the Canadian Food Inspection Agency recently reviewed information on the Company’s E3902 Camelina sativa and determined that E3902 is not a Plant with Novel Trait and is not subject to a pre-market notification under Part V of the Seeds Regulations.
-
USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States
3/21/2024
Yield10 Bioscience, Inc. announced that USDA-APHIS’s Biotechnology Regulatory Services has determined that Yield10’s Camelina sativa varieties developed using genetic engineering to produce omega-3 fatty acids are not subject to the regulations under 7 CFR part 340, and may be grown and bred in the United States.
-
Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests
2/29/2024
Yield10 Bioscience, Inc. reported that its proprietary varieties of winter Camelina sativa in development responded as expected to herbicides in the first field tests conducted in the United States.
-
Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock
2/14/2024
Yield10 Bioscience, Inc. and VISION Bioenergy Oilseeds, LLC announced that Yield10 has granted to VISION a global license to certain proprietary varieties of Camelina sativa for the production of feedstock oil for biofuels.
-
Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil
1/8/2024
Yield10 Bioscience, Inc. today announced that the Company recently filed a request for a Regulatory Status Review (“RSR”) with USDA-APHIS Biotechnology Regulatory Services for proprietary elite Camelina sativa ("Camelina”) varieties designed to produce seed oil containing both essential omega-3 fatty acids eicosapentaenoic acid (“EPA”) and docosahexaenoic acid (“DHA”).
-
USDA-APHIS Determines that Yield10 Bioscience’s Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States-Herbicide Technology Critical to Enabling Large-Acreage Adoption of Camelina in North America
11/15/2023
Yield10 Bioscience, Inc., an agricultural bioscience company, announced that the U.S. Department of Agriculture Animal & Plant Health Inspection Service’s Biotechnology Regulatory Services has determined that Yield10’s stacked herbicide tolerant Camelina sativa may be grown and bred in the United States.
-
USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States
11/15/2023
Yield10 Bioscience, Inc., an agricultural bioscience company, announced that USDA-APHIS’s Biotechnology Regulatory Services has determined that Yield10’s glufosinate tolerant Camelina sativa may be grown and bred in the United States.
-
Yield10 Bioscience Announces Third Quarter 2023 Financial Results
11/14/2023
Yield10 Bioscience, Inc., an agricultural bioscience company, reported financial results for the three and nine months ended September 30, 2023.
-
Yield10 Bioscience to Announce Third Quarter 2023 Financial Results and Host a Conference Call on Tuesday, November 14, 2023
11/8/2023
Yield10 Bioscience, Inc. today announced that the Company will report its third quarter 2023 financial results and provide a corporate update on Tuesday, November 14, 2023.
-
Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research
10/18/2023
Yield10 Bioscience, Inc. today announced that the Company has exercised its option to finalize an exclusive global, commercial license to advanced omega-3 production technology from U.K.
-
Yield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina
10/11/2023
Yield10 Bioscience, Inc. today announced recent advancements toward enabling weed control for Camelina cultivation and supporting grower adoption of the crop for production of low-carbon intensity feedstock oil for the biofuel market.
-
Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production
10/3/2023
Yield10 Bioscience, Inc. announced that the harvest of a majority of the winter and spring Camelina sativa grain produced under grower contracts in 2022/2023 has been completed.
-
Yield10 Bioscience to Present at the H.C. Wainwright 25th Annual Global Investment Conference
9/7/2023
Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that management will participate in the H.C. Wainwright 25th Annual Global Investment Conference being held on September 11-13, 2023, at the Lotte New York Palace Hotel.
-
Yield10 Bioscience Announces Closing of $3.7 Million Public Offering
8/15/2023
Yield10 Bioscience, Inc., an agricultural bioscience company, announced the closing of its previously announced public offering of 5,750,000 units at a public offering price of $0.65 per unit.
-
Yield10 Bioscience Announces Second Quarter 2023 Financial Results
8/14/2023
Yield10 Bioscience, Inc., an agricultural bioscience company, reported financial results for the three and six months ended June 30, 2023.
-
Yield10 Bioscience to Announce Second Quarter 2023 Financial Results and Host a Conference Call on Monday, August 14, 2023
8/11/2023
Yield10 Bioscience, Inc., an agricultural bioscience company, announced that the Company will report its second quarter 2023 financial results and provide a corporate update on Monday, August 14, 2023.
-
Yield10 Bioscience Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina, Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market
8/2/2023
Yield10 Bioscience, Inc. today announced positive results in the first field test of stacked herbicide tolerance (“HT”) traits in Camelina.
-
Yield10 Bioscience Files Request for Regulatory Status Review under USDA-APHIS’s SECURE Rule Covering Elite Camelina Designed to Produce the EPA Component of Omega-3 Oil
7/26/2023
Yield10 Bioscience, Inc. today announced that the Company recently filed a request for a Regulatory Status Review (RSR) with USDA-APHIS Biotechnology Regulatory Services (BRS) under the SECURE Rule for proprietary elite Camelina varieties containing genes enabling the plant to produce the eicosapentaenoic acid (“EPA”) component of omega-3 oil.